THERAPEUTIC COMPOSITION CONTAINING AT LEAST DIFLOMOTECAN AND CAPECITABIN E

摘要

Disclosed herein is the use of diflomotecan in synergistic combination withcapecitabine, for the preparation of a medicament intended to treat cancer.Alsodisclosed is the product comprising a first component consisting of atherapeuticallycomposition containing diflomotecan as active ingredient, and a secondcomponentconsisting of a therapeutically composition containing capecitabine as activeingredient, as synergistic combination product for simultaneous or separateuse, or usesequenced over time for treating cancer.